medigraphic.com
SPANISH

Revista Médica Electrónica

ISSN 1684-1824 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2013, Number 2

<< Back Next >>

Rev Méd Electrón 2013; 35 (2)

Herpes-kind dermatitis. Presentation of a case

Carballido LC, Darias DC, Fernández BA
Full text How to cite this article

Language: Spanish
References: 10
Page:
PDF size: 701.75 Kb.


Key words:

herpes-kind dermatitis, blistery dermatosis, dapsone.

ABSTRACT

We describe the herpes-kind dermatitis like a chronic blistery dermatosis that can appear at any age. Its frequency ranges from 10 to 39 per 100 000 persons, being less frequent in children. The herpes-kind dermatitis is characterized by a bullous blistery rash accompanied by an intense pruritus. We present the case of a male patient aged 2 years with an outbreak of herpes-kind vesical blistery lesions, and evolution of a month. We indicated a treatment of 2mg/kg a day dapsone, obtaining an excellent answer to the treatment. The scientific importance of the case is in the patient´s age, because of the disease´s scarce incidence in infantile ages, in the clinical diagnosis and the fast answer to the indicated treatment.


REFERENCES

  1. Fitzpatrich TB. Dermatitis herpetiforme. En: Dermatología en Medicina General. 6 ed. Mc Graw Hill. Panamericana; 2009

  2. Hbif TP. Clinical Dermatology. 4th ed. St. Louis, Mo: Mosbby; 2004.

  3. Sárdy M, Kárpáti S, Merkl B, Paulsson M, Smyth N. Epidermal Transglutaminase (tgase 3) is die autoantigen of dermatitis herpetiformis. J Exp Med. 2002 Mar 18;195(6):747-57. Citado en PubMed; PMID:11901200.

  4. Manssur J, Almeida J, Cortés. Dermatología. La Habana: Ciencias Médicas; 2002.

  5. Falabela R. Fundamentos de Medicina: Dermatología. 7ma.ed. Medellín, Colombia: CIB; 2009.

  6. Smith JB, Tulloch JE, Meyer LJ, Zone JJ.The incidence and prevalence of dermatitis herpetiforme in Utah. Arch Dermatol.1992; 128(12):1608-10. Citado en PubMed; PMID:1456754

  7. Lemarchand-Venecia F, Enjolras O. Dermatología et Maladies Sexuallement Transmisibles. SAURAT. 3er ed. París: MASSON; 1999.

  8. Odom RB, James WD, Berger TG. Berger. Andrews diseases of the skin: clinical Dermatology. St. Louis, Mo.; Mosby; 2000. Disponible en:http://www.getcited.org/pub

  9. De Las Heras E, Borbujo-Martínez J Form. Dermatitis herpetiforme. Form Med Contin Aten Prim[Internet]. 2006[citado 22 Nov 2012];13(3):140. Disponible en: http://www.elsevier.es/es/revistas/fmc-formacion-medica-continuada-atencion-primaria-45/dermatitis-herpetiforme-13085924-imagenes-2006?bd=1

  10. Green P, Cellier C. Celiac Disease. NEJM. 2007; 357(17): 1731-43. Citado en PubMed ;PMID: 17960014




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Méd Electrón. 2013;35